NNovo Nordisk Read More Novo Nordisk’s CagriSema Data Locked as Pipeline Hopes Wrestle With a 50% Stock Wipeout2026-04-27 Novo Nordisk locks Phase 3 data for CagriSema vs Lilly’s Tirzepatid in diabetes, with shares at half their…